This approval adds to Granules India's existing 67 ANDA approvals from the US FDA, strengthening its position in regulated ...

Granules India announced today that the U.S. Food & Drug Administration (USFDA) has approved the Abbreviated New Drug Application (ANDA) for Bupropion Hydrochloride Extended-Release Tablets USP (SR) ...

Bupropion hydrochloride extended-release tablets are widely prescribed for the treatment of major depressive disorder and for ...

Granules India has received USFDA approval to market a generic medication for major depressive disorder, Bupropion ...

Granules Pharmaceuticals, Inc., a 100% foreign subsidiary of Granules India received the U.S. Food & Drug Administration (USFDA) approval for abbreviated new drug application (ANDA) of Bupropion ...

A driver and passenger were arrested early Thursday morning after an officer located boxes of Promethazine Hyrdochloride and ...

The company has received approval for its Abbreviated New Drug Application for Bupropion Hydrochloride extended-release ...

The medication is widely prescribed for the treatment of major depressive disorder and for the prevention of seasonal ...

CARDOL contains sotalol hydrochloride as the active ingredient ... Do not take CARDOL if the packaging shows signs of tampering or the tablets do not look quite right. If you are not sure whether ...

Tap here to check the batch numbers and manufacturing dates of these drugs: 11. Fexofenadine Hydrochloride Tablets IP 120 mg 12. Fexofenadine Hydrochloride Tablets IP 120 mg 13. Laxnorm Solution ...

Opinion: An upcoming FDA ad comm on a treatment for the ultra rare Barth syndrome can’t use the normal measuring sticks for ...